Life Sciences Market Research Report
Report Filter Reset All
Sort By Price
Published Date
Category
Publishers
Report Type
Continents
Regions
Global Pegademase Bovine Market Insights, Forecast to 2025
Pegademase bovine Injection is a modified enzyme used for enzyme replacement therapy for the treatment of severe combined immunodeficiency. The global Pegade...
$3,900.00 22 May, 2019 | QYResearch
Global Pegademase Bovine Market Insights, Forecast to 2025
$3,900.00 | 22 May, 2019 | QYResearch
Pegademase bovine Injection is a modified enzyme used for enzyme replacement therapy for the treatment of severe combined immunodeficiency. The glo...
Global Pegademase Bovine Drugs Market Insights, Forecast to 2025
Pegademase bovine Injection is a modified enzyme used for enzyme replacement therapy for the treatment of severe combined immunodeficiency. The global Pegade...
$3,900.00 22 May, 2019 | QYResearch
Global Pegademase Bovine Drugs Market Insights, Forecast to 2025
$3,900.00 | 22 May, 2019 | QYResearch
Pegademase bovine Injection is a modified enzyme used for enzyme replacement therapy for the treatment of severe combined immunodeficiency. The glo...
Global Adagen Market Insights, Forecast to 2025
Adagen Injection is a modified enzyme used for enzyme replacement therapy for the treatment of severe combined immunodeficiency. The global Adagen market is ...
$3,900.00 22 May, 2019 | QYResearch
Global Adagen Market Insights, Forecast to 2025
$3,900.00 | 22 May, 2019 | QYResearch
Adagen Injection is a modified enzyme used for enzyme replacement therapy for the treatment of severe combined immunodeficiency. The global Adagen ...
Global Elapegademase-lvlr Market Insights, Forecast to 2025
Elapegademase-lvlr is indicated for the treatment of adenosine deaminase severe combined immune deficiency (ADA-SCID) in pediatric and adult patients. The gl...
$3,900.00 22 May, 2019 | QYResearch
Global Elapegademase-lvlr Market Insights, Forecast to 2025
$3,900.00 | 22 May, 2019 | QYResearch
Elapegademase-lvlr is indicated for the treatment of adenosine deaminase severe combined immune deficiency (ADA-SCID) in pediatric and adult patien...
Global Elapegademase-lvlr Drugs Market Insights, Forecast to 2025
Elapegademase-lvlr is indicated for the treatment of adenosine deaminase severe combined immune deficiency (ADA-SCID) in pediatric and adult patients. The gl...
$3,900.00 22 May, 2019 | QYResearch
Global Elapegademase-lvlr Drugs Market Insights, Forecast to 2025
$3,900.00 | 22 May, 2019 | QYResearch
Elapegademase-lvlr is indicated for the treatment of adenosine deaminase severe combined immune deficiency (ADA-SCID) in pediatric and adult patien...
Global Revcovi Market Insights, Forecast to 2025
Revcovi is indicated for the treatment of adenosine deaminase severe combined immune deficiency (ADA-SCID) in pediatric and adult patients. The global Revcov...
$3,900.00 22 May, 2019 | QYResearch
Global Revcovi Market Insights, Forecast to 2025
$3,900.00 | 22 May, 2019 | QYResearch
Revcovi is indicated for the treatment of adenosine deaminase severe combined immune deficiency (ADA-SCID) in pediatric and adult patients. The glo...
Global Adenosine Deaminase Deficiency Market Insights, Forecast to 2025
Adenosine deaminase deficiency is an autosomal recessive metabolic disorder that causes immunodeficiency. It occurs in fewer than one in 100,000 live births ...
$3,900.00 22 May, 2019 | QYResearch
Global Adenosine Deaminase Deficiency Market Insights, Forecast to 2025
$3,900.00 | 22 May, 2019 | QYResearch
Adenosine deaminase deficiency is an autosomal recessive metabolic disorder that causes immunodeficiency. It occurs in fewer than one in 100,000 li...
Global Adenosine Deaminase Deficiency Drugs Market Insights, Forecast to 2025
Adenosine deaminase deficiency is an autosomal recessive metabolic disorder that causes immunodeficiency. It occurs in fewer than one in 100,000 live births ...
$3,900.00 22 May, 2019 | QYResearch
Global Adenosine Deaminase Deficiency Drugs Market Insights, Forecast to 2025
$3,900.00 | 22 May, 2019 | QYResearch
Adenosine deaminase deficiency is an autosomal recessive metabolic disorder that causes immunodeficiency. It occurs in fewer than one in 100,000 li...
Global Adenosine Deaminase Deficiency Treatment Market Insights, Forecast to 2025
Adenosine deaminase deficiency is an autosomal recessive metabolic disorder that causes immunodeficiency. It occurs in fewer than one in 100,000 live births ...
$3,900.00 22 May, 2019 | QYResearch
Global Adenosine Deaminase Deficiency Treatment Market Insights, Forecast to 2025
$3,900.00 | 22 May, 2019 | QYResearch
Adenosine deaminase deficiency is an autosomal recessive metabolic disorder that causes immunodeficiency. It occurs in fewer than one in 100,000 li...
Global Adenosine Deaminase Deficiency Therapeutic Market Insights, Forecast to 2025
Adenosine deaminase deficiency is an autosomal recessive metabolic disorder that causes immunodeficiency. It occurs in fewer than one in 100,000 live births ...
$3,900.00 22 May, 2019 | QYResearch
Global Adenosine Deaminase Deficiency Therapeutic Market Insights, Forecast to 2025
$3,900.00 | 22 May, 2019 | QYResearch
Adenosine deaminase deficiency is an autosomal recessive metabolic disorder that causes immunodeficiency. It occurs in fewer than one in 100,000 li...
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
